Leonardo Zaninotto

Leonardo Zaninotto

Auto-generated profile, based on publicly available information

Leonardo Zaninotto

Department of Mental Health, Local Health Unit no. 6 ("Euganea"), Padova, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MSMarco Solm
Marco Solm
LZLeonardo Zaninotto
Leonardo Zaninotto
TTTommaso Toffanin
Tommaso Toffanin
Nicola VeroneseNicola Veronese
Nicola Veronese
KLKangguang Lin
Kangguang Lin
CCChristoph U. Correll
Christoph U. Correll

1 April 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LZLeonardo Zaninotto
Leonardo Zaninotto
MSMarco Solm
Marco Solm
TTTommaso Toffanin
Tommaso Toffanin
Nicola VeroneseNicola Veronese
Nicola Veronese
CCC. Robert Cloninger
C. Robert Cloninger
CCChristoph U. Correll
Christoph U. Correll

1 March 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LZLeonardo Zaninotto
Leonardo Zaninotto
RGRiccardo Guglielmo
Riccardo Guglielmo
Raffaella CalatiRaffaella Calati
Raffaella Calati
LILucia Ioime
Lucia Ioime
GCGiovanni Camardese
Giovanni Camardese
ASAlessandro Serretti
Alessandro Serretti

30 September 2016 in CNS Spectrums
Verified
Journal Article
Closed access
PDF file
MSMarco Solm
Marco Solm
Nicola VeroneseNicola Veronese
Nicola Veronese
LZLeonardo Zaninotto
Leonardo Zaninotto
MLMarc L. M. van der Loos
Marc L. M. van der Loos
KGKeming Gao
Keming Gao
CCChristoph U. Correll
Christoph U. Correll
Objectives: To meta-analytically summarize lamotrigine’s effectiveness and safety in unipolar and bipolar depression.Methods: We conducted systematic PubMed and SCOPUS reviews (last search =10/01/2015) of randomized controlled trials comparing lamotrigine to placebo or other agents with antidepressant activity in unipolar or bipolar depression. We performed a random-effects meta-analysis of depression ratings, response, remission, and adverse effects calculating standardized mean difference (SMD) and risk ratio (RR) ±95% confidence intervals (CIs).Results: Eighteen studies (n=2152, duration=9.83 weeks) in patients with unipolar depression (studies=4, n=187; monotherapy vs lithium=1, augmentation of antidepressants vs placebo=3) or bipolar depression (studies=14, n=1965; monotherapy vs placebo=5, monotherapy vs lithium or olanzapine+fluoxetine=2, augmentation of antidepressants vs placebo=1, augmentation of mood stabilizers vs placebo=3, augmentation of mood stabilizers vs trancylpromine, citalopram, or inositol=3) were meta-analyzed. Lamotrigine’s efficacy for depressive symptoms did not differ significantly in monotherapy vs augmentation studies (vs. placebo: p=0.98, I2=0%; vs active agents: p=0.48, I2=0%) or in unipolar vs bipolar patients (vs placebo: p=0.60, I2=0%), allowing pooling of each placebo-controlled and active-controlled trials. Lamotrigine outperformed placebo regarding depressive symptoms (studies=11, n=713 vs n=696; SMD=–0.15, 95% CI=–0.27, –0.02, p=0.02, heterogeneity: p=0.24) and response (after removing one extreme outlier; RR=1.42, 95% CI=1.13–1.78; p=0.003, heterogeneity: p=0.08). Conversely, lamotrigine did not differ regarding efficacy on depressive symptoms, response, or remission from lithium, olanzapine+fluoxetine, citalopram, or inositol (studies=6, n=306 vs n=318, p-values=0.85–0.92). Adverse effects and all-cause/specific-cause discontinuation were similar across all comparisons.Conclusions: Lamotrigine was superior to placebo in improving unipolar and bipolar depressive symptoms, without causing more frequent adverse effects/discontinuations. Lamotrigine did not differ from lithium, olanzapine+fluoxetine, citalopram, or inositol.

1 September 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LZLeonardo Zaninotto
Leonardo Zaninotto
MSMarco Solm
Marco Solm
Nicola VeroneseNicola Veronese
Nicola Veronese
RGRiccardo Guglielmo
Riccardo Guglielmo
LILucia Ioime
Lucia Ioime
ASAlessandro Serretti
Alessandro Serretti

1 June 2018 in Psychiatry Research
Verified
Journal Article
Closed access
LZLeonardo Zaninotto
Leonardo Zaninotto
GRGenny Rossi
Genny Rossi
ADAndrea Danieli
Andrea Danieli
AFAlberto Frasson
Alberto Frasson
LMLeonardo Meneghetti
Leonardo Meneghetti
MSMarco Solm
Marco Solm